4//SEC Filing
NYER MEDICAL GROUP INC 4
Accession 0001140361-08-003026
CIK 0000884647operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:05 PM ET
Size
15.4 KB
Accession
0001140361-08-003026
Insider Transaction Report
Form 4
Dumouchel Mark
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2008-02-04+12,000→ 12,000 totalExercise: $1.49From: 2009-02-04Exp: 2018-02-03→ Common Stock (12,000 underlying) - Award
Convertible Note
2008-02-04Exercise: $1.84From: 2009-02-04→ Common Stock (163,043 underlying) - Award
Series 2 Class B Preferred Stock
2008-02-04+400→ 400 totalExercise: $1.84→ Common Stock (43,478 underlying) - Purchase
Common Stock
2008-02-04$1.84/sh+119,566$220,001→ 119,566 total
Footnotes (5)
- [F1]The Series 2 Class B Preferred Stock is convertible at the option of the shareholder in the event of a merger or sale of Nyer Medical Group, Inc., or on or after February 4, 2011.
- [F2]The Series 2 Class B Preferred Stock is subject to mandatory conversion on or after February 4, 2011, so long as there are no events of default existing under certain of the Company's indebtedness and there is an effective resale registration statement filed with respect to the shares of common stock to be issued upon conversion.
- [F3]Mark Dumouchel was a minority shareholder of D.A.W., Inc., a subsidiary of Nyer Medical Group, Inc., and acquired the 400 Shares of Series 2 Class B Preferred Stock and the Convertible Note in connection with Nyer Medical Group, Inc.'s acquisition of the minority interest in D.A.W., Inc.
- [F4]The Convertible Note maturity date is February 4, 2011.
- [F5]Options for 2,000 shares are exercisable on each of 06/30/2008, 12/31/2008, 06/30/2009, 12/31/2009, 06/30/2010 and 12/31/2010.
Documents
Issuer
NYER MEDICAL GROUP INC
CIK 0000884647
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0000884647
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 6:05 PM ET
- Size
- 15.4 KB